This week's View focuses again on the COVID-19 resources on ACC.org, featuring an article on whether patients with hypertension who are taking angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers have an increased mortality risk during hospitalization for COVID-19, key points to remember from a perspective on antiplatelet therapy following percutaneous coronary intervention in patients complicated by COVID-19, and an article describing the experience of COVID-19 screening of health care workers in England.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: Cardiovascular Care Team, COVID-19 Hub, Diabetes and Cardiometabolic Disease, Dyslipidemia, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Lipid Metabolism, Interventions and Imaging, Angiography, Nuclear Imaging, Hypertension

Keywords: EaglesEyeView, Adenosine, Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists, Antihypertensive Agents, Aspirin, Blood Platelets, Comorbidity, Coronavirus, Coronavirus Infections, Cough, COVID-19, ACC COVID-19 Podcast, Electronic Mail, Equilibrative Nucleoside Transporter 1, Fever, Fibrin, General Practitioners, Hemorrhage, Hemostasis, Hospital Mortality, Hypertension, Nurses, Occupational Health, Pandemics, Percutaneous Coronary Intervention, Personal Protective Equipment, Platelet Aggregation Inhibitors, Pneumonia, Viral, Primary Prevention, Public Health, Purinergic P2Y Receptor Antagonists, Reverse Transcription, RNA-Dependent RNA Polymerase, SARS Virus, severe acute respiratory syndrome coronavirus 2, Thrombocytopenia, Thrombosis, Dyslipidemias, Coronary Angiography

< Back to Listings